Paul B Manning acquired an additional 25.4% stake in Taysha Gene Therapies, Inc. for $14.82 million.
Paul B Manning completed the acquisition of an additional 25.4% stake in Taysha Gene Therapies, Inc. (NasdaqGS:TSHA) on August 16, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.17 USD | +6.65% | +8.03% | +135.59% |
14/05 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
14/05 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
1st Jan change | Capi. | |
---|---|---|
+135.59% | 780M | |
+46.03% | 55.66B | |
-7.53% | 38.98B | |
+36.84% | 38.8B | |
-9.38% | 27.32B | |
+12.31% | 26.29B | |
-16.38% | 20.25B | |
+30.79% | 12.76B | |
+28.57% | 12.18B | |
-0.36% | 12.12B |